ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

NCT00493506 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Hepatitis B
Dyslipidemia

Interventions

DRUG: ProAlgaZyme

Sponsor

Health Enhancement Products, Inc.

Collaborators

[object Object]